Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn J Barst

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Infection Control and Hospital Epidemiology|May 9, 2008
Bloodstream infections in patients given treatment with intravenous prostanoidsAlexander J Kallen, Edith Lederman, Alexandra Balaji, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2010
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapyHossein A Ghofrani, Nicholas W Morrell, Marius M Hoeper, et al.
The New England Journal of Medicine|March 22, 2002
Bosentan therapy for pulmonary arterial hypertensionLewis J Rubin, David B Badesch, Robyn J Barst, et al.
American Journal of Respiratory and Critical Care Medicine|March 5, 2003
Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertensionHilario Nunes, Marc Humbert, Olivier Sitbon, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2006
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertensionVallerie V McLaughlin, Ronald J Oudiz, Adaani Frost, et al.
Journal of the American College of Cardiology|January 15, 2008
Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertensionD Dunbar Ivy, Aimee K Doran, Kelly J Smith, et al.
American Journal of Respiratory and Critical Care Medicine|March 19, 2002
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trialGerald Simonneau, Robyn J Barst, Nazzareno Galie, et al.
Chest|May 7, 2011
Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 studyLewis J Rubin, David B Badesch, Thomas R Fleming, et al.
The New England Journal of Medicine|November 18, 2005
Sildenafil citrate therapy for pulmonary arterial hypertensionNazzareno Galiè, Hossein A Ghofrani, Adam Torbicki, et al.
Circulation|May 28, 2009
Tadalafil therapy for pulmonary arterial hypertensionNazzareno Galiè, Bruce H Brundage, Hossein A Ghofrani, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Infection Control and Hospital Epidemiology|May 9, 2008
Bloodstream infections in patients given treatment with intravenous prostanoidsAlexander J Kallen, Edith Lederman, Alexandra Balaji, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2010
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapyHossein A Ghofrani, Nicholas W Morrell, Marius M Hoeper, et al.
The New England Journal of Medicine|March 22, 2002
Bosentan therapy for pulmonary arterial hypertensionLewis J Rubin, David B Badesch, Robyn J Barst, et al.
American Journal of Respiratory and Critical Care Medicine|March 5, 2003
Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertensionHilario Nunes, Marc Humbert, Olivier Sitbon, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2006
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertensionVallerie V McLaughlin, Ronald J Oudiz, Adaani Frost, et al.
Journal of the American College of Cardiology|January 15, 2008
Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertensionD Dunbar Ivy, Aimee K Doran, Kelly J Smith, et al.
American Journal of Respiratory and Critical Care Medicine|March 19, 2002
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trialGerald Simonneau, Robyn J Barst, Nazzareno Galie, et al.
Chest|May 7, 2011
Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 studyLewis J Rubin, David B Badesch, Thomas R Fleming, et al.
The New England Journal of Medicine|November 18, 2005
Sildenafil citrate therapy for pulmonary arterial hypertensionNazzareno Galiè, Hossein A Ghofrani, Adam Torbicki, et al.
Circulation|May 28, 2009
Tadalafil therapy for pulmonary arterial hypertensionNazzareno Galiè, Bruce H Brundage, Hossein A Ghofrani, et al.
Pageof 14